サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1404601

浮腫臨床試験市場規模、シェア、動向分析レポート：フェーズ別、市場参入企業別、試験デザイン別、タイプ別、地域別、セグメント別予測、2023年～2030年

Edema Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Participant, By Study Design, By Type, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
浮腫臨床試験市場規模、シェア、動向分析レポート：フェーズ別、市場参入企業別、試験デザイン別、タイプ別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年11月07日
発行: Grand View Research
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

浮腫臨床試験市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の浮腫臨床試験市場規模は、2023年から2030年にかけてCAGR5.7％を記録し、2030年までに12億7,000万米ドルに達する見込みです。

市場の成長を促進するいくつかの要因には、心不全、腎障害、肝硬変などの基礎疾患による浮腫の有病率の増加、医療研究における医療開発への支出の増加などがあります。

さらに、浮腫の調査研究は市場の拡大を促進すると予測されています。例えば、2021年8月、Novartis社は、糖尿病黄斑浮腫を治療するBeovuの第III相試験から有望な知見を発表し、最大16週間の投与間隔で有効な結果を示しました。KITE試験の2年目100週目の結果では、ローディングフェーズと最初の12週間サイクルを終えた患者のほとんどが、試験終了まで12週間または16週間の投与間隔を保った。

浮腫臨床試験市場レポートハイライト

  • フェーズIIセグメントでは、有効性と安全性の両方を評価するため、より多くの患者群でより広範な試験が行われるためです。このような試験は、投与量の改良、副作用の特定、治療効果の予備的証拠の収集を目的としています。
  • 第III相セグメントは、大規模で多様な患者集団における治療の有効性と安全性の強力なエビデンスを提供することが、規制当局の承認を得るために極めて重要であるため、予測期間中にCAGR 5.5％で成長すると予想されます。
  • 参加者に基づくと、成人セグメントは2022年に48.9%と最大の売上シェアを占めました。これは、成人セグメントはより長期にわたる病歴があり、その起源と重症度に関してより多様な集団である可能性があるためです。
  • 試験デザインに基づくと、介入試験セグメントは2022年に48.2%と最大の収益シェアを占め、予測期間中最も速いCAGR 5.8%で成長すると予測されます。このデザインでは、複数の国や地域から参加者を集め、多施設での手法が頻繁に使用されます。
  • タイプ別では、局所性浮腫セグメントが2022年に63.5%と最大の収益シェアを占めました。一部の集団における局所性浮腫の頻度と強度は、特定の地域やヘルスケア環境での臨床試験における重要性を高めるであろう。
  • 2022年には、北米が41.4％の売上シェアで市場を独占しました。北米は学術機関、研究施設、臨床試験のための場所で構成されているからです。また、先進的で堅牢な研究インフラも整備されています。アジア太平洋地域は、予測期間中最も速いCAGR 6.1％で成長すると予測され、中国やインドなどの国々が医薬品生産と研究の重要な拠点となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 事業環境分析
    • PESTLE分析
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 フェーズのビジネス分析

  • 浮腫臨床試験市場：相変動分析、2022年および2030年
  • フェーズI
    • フェーズ I市場、2018年～2030年
  • フェーズ II
    • フェーズ II市場、2018年～2030年
  • フェーズⅢ
    • フェーズ III市場、2018年～2030年
  • フェーズ IV
    • フェーズ IV市場、2018年～2030年

第5章 参加者のビジネス分析

  • 浮腫臨床試験市場：参加者の変動分析、2022年および2030年
  • 小児科
  • 大人
  • 老人医学

第6章 スポンサービジネス分析

  • 浮腫臨床試験市場：スポンサー変動分析、2022年および2030年
  • 製薬会社
    • 製薬会社市場、2018年～2030年
  • 学術機関
    • 学術機関市場、2018年～2030年
  • 政府機関
    • 政府機関市場、2018年～2030年

第7章 タイプビジネス分析

  • 浮腫臨床試験市場：タイプの変動分析、2022年および2030年
  • 全身性浮腫
  • 局所性浮腫

第8章 地域ビジネス分析

  • 地域市場のスナップショット
  • 北米
    • 北米浮腫臨床試験市場、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州浮腫臨床試験市場、2018年～2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋の浮腫臨床試験市場、2018年～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの浮腫臨床試験市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA浮腫臨床試験市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 取得
    • コラボレーション
    • 新しいプラットフォームの発表
    • その他
  • 企業プロファイル・一覧表
    • Otsuka Holdings
    • Hoffmann-La Roche
    • Novartis Pharmaceuticals
    • Bayer
    • Genentech, Inc
    • Biogen
    • Johnson &Johnson
    • Merck &Co., Inc.
    • Sanofi SA
    • AstraZeneca plc
    • Bristol Myers Squibb Company
    • GlaxoSmithKline plc
    • AbbVie Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 Global Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 5 Global Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 6 Global Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 7 Global Edema Clinical Trial Market by Region, 2018 - 2030 (USD Million)
  • Table 8 North America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 10 North America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 11 North America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 12 North America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 13 U.S. Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 14 U.S. Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 15 U.S. Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 16 U.S. Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 17 Canada Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 18 Canada Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 19 Canada Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 20 Canada Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 23 Europe Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 24 Europe Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 25 Europe Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 27 Germany Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 28 Germany Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 29 Germany Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 30 UK Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 31 UK Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 32 UK Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 33 UK Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 34 France Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 35 France Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 36 France Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 37 France Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 38 Italy Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 39 Italy Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 40 Italy Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 41 Italy Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 42 Spain Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 43 Spain Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 44 Spain Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 45 Spain Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 46 Denmark Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 47 Denmark Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 48 Denmark Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 49 Denmark Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 50 Sweden Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 51 Sweden Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 52 Sweden Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 53 Sweden Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 54 Norway Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 55 Norway Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 56 Norway Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 57 Norway Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 63 China Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 64 China Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 65 China Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 66 China Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 67 Japan Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 68 Japan Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 69 Japan Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 70 Japan Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 71 India Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 72 India Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 73 India Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 74 India Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 75 South Korea Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 76 South Korea Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 77 South Korea Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 78 South Korea Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 79 Australia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 80 Australia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 81 Australia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 82 Australia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 83 Thailand Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 84 Thailand Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 85 Thailand Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 86 Thailand Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 87 Latin America Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 88 Latin America Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 89 Latin America Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 90 Latin America Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 91 Latin America Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 92 Brazil Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 93 Brazil Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 94 Brazil Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 95 Brazil Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 96 Mexico Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 97 Mexico Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 98 Mexico Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 99 Mexico Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 100 Argentina Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 101 Argentina Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 102 Argentina Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 103 Argentina Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Edema Clinical Trial Market by Country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 109 South Africa Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 110 South Africa Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 111 South Africa Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 112 South Africa Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 117 UAE Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 118 UAE Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 119 UAE Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 120 UAE Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)
  • Table 121 Kuwait Edema Clinical Trial Market By Phase, 2018 - 2030 (USD Million)
  • Table 122 Kuwait Edema Clinical Trial Market by Participant, 2018 - 2030 (USD Million)
  • Table 123 Kuwait Edema Clinical Trial Market By Sponsor, 2018 - 2030 (USD Million)
  • Table 124 Kuwait Edema Clinical Trial Market By Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Edema Clinical Trial Market: Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Edema Clinical Trial Market for Phase I, 2018 - 2030 (USD Million)
  • Fig. 16 Global Edema Clinical Trial Market for Phase II, 2018 - 2030 (USD Million)
  • Fig. 17 Global Edema Clinical Trial Market for Phase III, 2018 - 2030 (USD Million)
  • Fig. 18 Global Edema Clinical Trial Market for Phase IV, 2018 - 2030 (USD Million)
  • Fig. 19 Global Edema Clinical Trial Market for Pediatrics , 2018 - 2030 (USD Million)
  • Fig. 20 Global Edema Clinical Trial Market for Adults, 2018 - 2030 (USD Million)
  • Fig. 21 Global Edema Clinical Trial Market for Geriatrics, 2018 - 2030 (USD Million)
  • Fig. 22 Global Edema Clinical Trial Market for Pharmaceutical Companies, 2018 - 2030 (USD Million)
  • Fig. 23 Global Edema Clinical Trial Market for Academic Institutions, 2018 - 2030 (USD Million)
  • Fig. 24 Global Edema Clinical Trial Market for Government Bodies, 2018 - 2030 (USD Million)
  • Fig. 25 Global Edema Clinical Trial Market for Systemic Edema, 2018 - 2030 (USD Million)
  • Fig. 26 Global Edema Clinical Trial Market for Localized Edema, 2018 - 2030 (USD Million)
  • Fig. 27 Regional Outlook, 2022 & 2030
  • Fig. 28 North America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 30 Canada Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 31 Europe Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 32 Germany Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 33 UK Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 34 France Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 35 Italy Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 36 Spain Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 39 Norway Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 41 Japan Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 42 China Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 43 India Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 44 Australia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 54 UAE Edema Clinical Trial Market 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Edema Clinical Trial Market 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-117-8

Edema Clinical Trials Market Growth & Trends:

The global edema clinical trials market size is expected to reach USD 1.27 billion by 2030, registering a compound annual growth rate (CAGR) of 5.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Several factors driving the growth of the market include the increasing prevalence of edema caused by underlying illnesses such as heart failure, kidney disorders, and liver cirrhosis, increasing expenditures on health care developments in medical research, among others.

In addition, edema research studies are anticipated to fuel the market's expansion. For instance, in August 2021, Novartis announced encouraging findings from Phase III studies of Beovu treating diabetic macular edema, showing effective outcomes at up to 16-week intervals between doses. The KITE study's results from week 100 of the second year showed that most patients who finished the loading phases and the first 12-week cycle were kept on a 12 or 16-week dosing interval until the study's end.

Edema Clinical Trials Market Report Highlights:

  • Based on phase, the phase-II segment accounted for the largest revenue share of 35.7% in 2022, as there is more extensive testing in a larger group of patients to assess both efficacy and safety in the phase-II segment. These trials aim to refine the dosage, identify adverse effects, and gather preliminary evidence of the treatment's effectiveness
  • The phase-III segment is expected to grow at a CAGR of 5.5% during the forecast period, as it is crucial for obtaining regulatory approval to provide strong evidence of a treatment's effectiveness and safety in a large, diverse patient population
  • Based on participant, the adult segment accounted for the largest revenue share of 48.9% in 2022 due to the possibility that they have a more extended history of the condition and a more diverse population regarding its origin and severity
  • Based on study design, the interventional trials segment accounted for the largest revenue share of 48.2% in 2022 and is expected to grow at the fastest CAGR of 5.8% over the forecast period. This design takes people from several countries and areas and frequently uses a multicenter technique
  • Based on type, the localized edema segment accounted for the largest revenue share of 63.5% in 2022. The frequency and intensity of localized edema in some populations would increase its significance in clinical trials for particular geographic areas or healthcare settings
  • In 2022, North America dominated the market with a revenue share of 41.4% as it consists of academic institutions, research facilities, and places for clinical trials. It also offers an advanced and robust research infrastructure. Asia Pacific is anticipated to grow at the fastest CAGR of 6.1% over the forecast period, with countries such as China and India serving as significant centers for pharmaceutical production and research

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Phase Business Analysis

  • 4.1. Edema Clinical Trials Market: Phase Movement Analysis, 2022 & 2030
  • 4.2. Phase I
    • 4.2.1. Phase I Market, 2018 - 2030 (USD Million)
  • 4.3. Phase II
    • 4.3.1. Phase II Market, 2018 - 2030 (USD Million)
  • 4.4. Phase III
    • 4.4.1. Phase III Market, 2018 - 2030 (USD Million)
  • 4.5. Phase IV
    • 4.5.1. Phase IV Market, 2018 - 2030 (USD Million)

Chapter 5. Participant Business Analysis

  • 5.1. Edema Clinical Trials Market: Participant Movement Analysis, 2022 & 2030
  • 5.2. Pediatrics
    • 5.2.1. Pediatric Market, 2018 - 2030 (USD Million)
  • 5.3. Adults
    • 5.3.1. Adults Market, 2018 - 2030 (USD Million)
  • 5.4. Geriatrics
    • 5.4.1. Geriatrics Market, 2018 - 2030 (USD Million)

Chapter 6. Sponsor Business Analysis

  • 6.1. Edema Clinical Trials Market: Sponsor Movement Analysis, 2022 & 2030
  • 6.2. Pharmaceutical Companies
    • 6.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 6.3. Academic Institutions
    • 6.3.1. Academic Institutions Market, 2018 - 2030 (USD Million)
  • 6.4. Government Bodies
    • 6.4.1. Government Bodies Market, 2018 - 2030 (USD Million)

Chapter 7. Type Business Analysis

  • 7.1. Edema Clinical Trials Market: Type Movement Analysis, 2022 & 2030
  • 7.2. Systemic Edema
    • 7.2.1. Systemic Edema Market, 2018 - 2030 (USD Million)
  • 7.3. Localized Edema
    • 7.3.1. Localized Edema Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Competitive Scenario
    • 8.5.3. Mexico
      • 8.5.3.1. Mexico Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Competitive Scenario
    • 8.5.4. Argentina
      • 8.5.4.1. Argentina Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.5.4.2. Key Country Dynamics
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Edema Clinical Trials Market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Edema Clinical Trials Market, 2018 - 2030 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. Otsuka Holdings
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Platform Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Hoffmann-La Roche
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Platform Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Novartis Pharmaceuticals
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Platform Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Bayer
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Platform Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Genentech, Inc
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Platform Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Biogen
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Platform Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. Johnson & Johnson
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Platform Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Merck & Co., Inc.
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Platform Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Sanofi S.A.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Platform Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. AstraZeneca plc
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Platform Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Bristol Myers Squibb Company
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Platform Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. GlaxoSmithKline plc
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Platform Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. AbbVie Inc.
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Platform Benchmarking
      • 9.3.13.4. Strategic Initiatives